Brief: Atara Biotherapeutics Q3 EPS USD -2.93
12/11/2024 21:01
Nov 12 (Reuters) - Atara Biotherapeutics Q3 revenue USD 40.19 million vs. IBES estimate USD 35.2 million. * Q3 operating income USD -21.757 million * Q3 net income USD -21.909 million
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing